Delenko Julia, Xue Xiangying, Chatterjee Prodyot K, Hyman Nathaniel, Shih Andrew J, Adelson Robert P, Safaric Tepes Polona, Gregersen Peter K, Metz Christine N
The Donald and Barbara Zucker School of Medicine, Hempstead, NY, 11549, USA.
The Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.
Reprod Biol Endocrinol. 2024 Aug 8;22(1):100. doi: 10.1186/s12958-024-01265-z.
Patients with endometriosis suffer with chronic pelvic pain and infertility, and from the lack of pharmacologic therapies that consistently halt disease progression. Differences in the endometrium of patients with endometriosis vs. unaffected controls are well-documented. Specifically, shed endometrial tissues (delivered to the pelvic cavity via retrograde menstruation) reveal that a subset of stromal cells exhibiting pro-inflammatory, pro-fibrotic, and pro-senescence-like phenotypes is enhanced in endometriosis patients compared to controls. Additionally, cultured biopsy-derived endometrial stromal cells from endometriosis patients exhibit impaired decidualization, a defined differentiation process required for human embryo implantation and pregnancy. Quercetin, a senolytic agent, shows therapeutic potential for pulmonary fibrosis, a disorder attributed to senescent pulmonary fibroblasts. In rodent models of endometriosis, quercetin shows promise, and quercetin improves decidualization in vitro. However, the exact mechanisms are not completely understood. Therefore, we investigated the effects of quercetin on menstrual effluent-derived endometrial stromal cells from endometriosis patients and unaffected controls to define the signaling pathways underlying quercetin's effects on endometrial stromal cells.
Menstrual effluent-derived endometrial stromal cells were collected and cultured from unaffected controls and endometriosis patients and then, low passage cells were treated with quercetin (25 µM) under basal or standard decidualization conditions. Decidualization responses were analyzed by measuring the production of IGFBP1 and PRL. Also, the effects of quercetin on intracellular cAMP levels and cellular oxidative stress responses were measured. Phosphokinase arrays, western blotting, and flow cytometry methods were performed to define the effects of quercetin on various signaling pathways and the potential mechanistic roles of quercetin.
Quercetin significantly promotes decidualization of control- and endometriosis-endometrial stromal cells. Quercetin substantially reduces the phosphorylation of multiple signaling molecules in the AKT and ERK1/2 pathways, while enhancing the phosphorylation of p53 and total p53 levels. Furthermore, p53 inhibition blocks decidualization while p53 activation promotes decidualization. Finally, we provide evidence that quercetin increases apoptosis of endometrial stromal cells with a senescent-like phenotype.
These data provide insight into the mechanisms of action of quercetin on endometrial stromal cells and warrant future clinical trials to test quercetin and other senolytics for treating endometriosis.
子宫内膜异位症患者饱受慢性盆腔疼痛和不孕之苦,且缺乏能持续阻止疾病进展的药物治疗方法。子宫内膜异位症患者与未受影响的对照组相比,其子宫内膜存在差异,这一点已有充分记录。具体而言,脱落的子宫内膜组织(通过逆行月经进入盆腔)显示,与对照组相比,子宫内膜异位症患者中表现出促炎、促纤维化和早衰样表型的一部分基质细胞有所增加。此外,来自子宫内膜异位症患者的培养活检来源的子宫内膜基质细胞表现出蜕膜化受损,蜕膜化是人类胚胎着床和妊娠所需的特定分化过程。槲皮素是一种促衰老药物,对肺纤维化(一种由衰老的肺成纤维细胞引起的疾病)显示出治疗潜力。在子宫内膜异位症的啮齿动物模型中,槲皮素显示出前景,并且槲皮素在体外可改善蜕膜化。然而,确切机制尚未完全明确。因此,我们研究了槲皮素对来自子宫内膜异位症患者和未受影响的对照组的月经流出物来源的子宫内膜基质细胞的影响,以确定槲皮素对子宫内膜基质细胞作用的信号通路。
从未受影响的对照组和子宫内膜异位症患者中收集并培养月经流出物来源的子宫内膜基质细胞,然后在基础或标准蜕膜化条件下用槲皮素(25μM)处理低代细胞。通过测量胰岛素样生长因子结合蛋白1(IGFBP1)和催乳素(PRL)的产生来分析蜕膜化反应。此外,还测量了槲皮素对细胞内cAMP水平和细胞氧化应激反应的影响。采用磷酸激酶阵列、蛋白质免疫印迹法和流式细胞术来确定槲皮素对各种信号通路的影响以及槲皮素的潜在作用机制。
槲皮素显著促进对照组和子宫内膜异位症患者的子宫内膜基质细胞的蜕膜化。槲皮素大幅降低AKT和ERK1/2通路中多个信号分子的磷酸化水平,同时增强p53的磷酸化水平和总p53水平。此外,抑制p53会阻断蜕膜化,而激活p53则会促进蜕膜化。最后,我们提供证据表明槲皮素可增加具有衰老样表型的子宫内膜基质细胞的凋亡。
这些数据为槲皮素对子宫内膜基质细胞的作用机制提供了见解,并为未来测试槲皮素和其他促衰老药物治疗子宫内膜异位症的临床试验提供了依据。